A caution on the use of murine hemophilia models for comparative immunogenicity studies of FVIII products with different protein compositions

Thromb Haemost. 2003 Jun;89(6):1110-2; author reply 1113.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Factor VIII / immunology*
  • Factor VIII / standards
  • Factor VIII / therapeutic use
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology
  • Humans
  • Immunity
  • Mice
  • Proteins

Substances

  • Proteins
  • Factor VIII